Rohto Pharmaceutical Co.,Ltd.

TSE:4527 Stok Raporu

Piyasa değeri: JP¥626.1b

Rohto PharmaceuticalLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Rohto PharmaceuticalLtd yıllık ortalama 19.2% oranında kazançlarını artırırken, Personal Products sektöründe kazançlar growing at 5.8% annual. Gelirler growing yılda ortalama 10.1% oranında artmaktadır. Rohto PharmaceuticalLtd'in özkaynak karlılığı 10.4% ve net marjı 9.7%'dir.

Anahtar bilgiler

19.2%

Kazanç büyüme oranı

19.2%

EPS büyüme oranı

Personal Products Sektör Büyümesi5.4%
Gelir büyüme oranı10.1%
Özkaynak getirisi10.4%
Net Marj9.7%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 15
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07
Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well

Oct 20
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price

Oct 06
Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price

Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down

Sep 22
Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down

Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors

Aug 25
Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors

Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next

Aug 11
Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next

Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?

Jul 11
Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Jun 23
Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares

Jun 10
Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares

Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

May 14
Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Apr 03
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Mar 21
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Feb 26
Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Gelir ve Gider Dağılımı

Rohto PharmaceuticalLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:4527 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24282,05327,263109,25413,390
30 Jun 24278,02530,328104,51913,390
31 Mar 24270,84030,936101,30613,390
31 Dec 23263,56430,89799,52711,065
30 Sep 23256,22029,77997,05411,065
30 Jun 23247,58028,47393,41111,065
31 Mar 23238,66426,37790,47911,065
31 Dec 22231,88725,72289,0988,740
30 Sep 22218,94023,45484,2628,740
30 Jun 22209,58623,28180,3448,740
31 Mar 22199,64621,01877,4608,740
31 Dec 21195,69822,59376,6367,903
30 Sep 21189,30221,32176,2727,903
30 Jun 21184,96119,53775,0197,903
31 Mar 21181,28716,74375,1477,903
31 Dec 20179,81913,93177,9977,050
30 Sep 20180,90314,28378,0527,050
30 Jun 20185,05815,13080,8407,050
31 Mar 20188,32715,41082,7337,050
31 Dec 19187,00611,49082,3216,831
30 Sep 19186,7519,78782,5486,831
30 Jun 19184,8548,57682,1926,831
31 Mar 19183,5829,79980,6026,831
31 Dec 18182,32810,05880,1896,553
30 Sep 18180,50310,95978,7526,553
30 Jun 18176,54310,45476,1776,553
31 Mar 18171,7429,28974,1066,553
31 Dec 17167,28611,69972,4406,123
30 Sep 17161,79911,46769,9296,123
30 Jun 17157,55710,91368,7836,123
31 Mar 17154,59910,01168,4146,123
31 Dec 16158,1159,70569,5385,811
30 Sep 16160,9738,41673,0025,811
30 Jun 16164,4679,14374,1405,811
31 Mar 16167,0169,09876,2415,811
31 Dec 15164,63910,59175,7465,585
30 Sep 15161,8529,92674,7095,585
30 Jun 15157,1679,31172,3175,585
31 Mar 15151,7748,63170,5515,585
31 Dec 14148,1676,60869,4234,547
30 Sep 14146,4958,00266,8554,547
30 Jun 14143,9007,67665,3964,547
31 Mar 14143,8228,94763,7174,547
31 Dec 13139,6139,18361,3434,062

Kaliteli Kazançlar: 4527 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 4527 'nin mevcut net kar marjları (9.7%) geçen yılın (11.6%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 4527 şirketinin kazancı son 5 yılda yılda 19.2% oranında arttı.

Büyüme Hızlandırma: 4527 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: 4527 geçtiğimiz yıl negatif kazanç büyümesine ( -8.4% ) sahipti ve bu da onu Personal Products sektör ortalamasıyla ( -6.6% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: 4527 'nin Özsermaye Getirisi ( 10.4% ) düşük olarak değerlendiriliyor.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y